Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Health Yuan Wins Cailian Press's 'Social Responsibility Pioneer Enterprise Award' for Deeply Implementing ESG Principles
Published Time：
2022-12-12
Recently, the "Diligence and Far-Reaching: 2022 Cailian Press Third ESG Enterprise Summit and 2022 Cailian Press 'Far-Reaching Award' Ceremony" was grandly held in Shanghai. HealthGen, with its outstanding performance in fulfilling social responsibilities, promoting industry development, and driving innovation, won the Cailian Press Far-Reaching Award for Socially Responsible Pioneer Enterprise.
It is understood that this event was guided by the Shanghai United Media Group and hosted by Cailian Press, with the theme of "Diligence and Far-Reaching." It brought together numerous elites from government, business, and academia, including renowned scholars, business representatives, and financial institution representatives, to discuss and exchange ideas on multi-dimensional topics such as ESG investment, corporate ESG actions, and green finance. The aim is to focus on ESG development topics, promote ESG concepts, drive the development of green finance, and promote the sustainable development of China's capital market.
ESG is increasingly becoming an important investment philosophy in the financial market and a guiding principle for corporate actions. As a comprehensive pharmaceutical group in Shenzhen with a high sense of social responsibility, HealthGen closely integrates ESG concepts with its development strategy. It actively explores and develops the inhaled formulation industry, aiming to break the monopoly of foreign original research companies in the huge domestic market, striving to solve the accessibility of medicines for the people, contributing to the development of the domestic inhaled formulation industry, and striving to become a pioneer in the greater health industry, achieving the synergistic development of economic, environmental, and social value.
To thoroughly implement the ESG concept, HealthGen formulated the "2021-2025 Energy Conservation and Emission Reduction Work Goals," continuously promoting energy conservation and emission reduction work in its subordinate production enterprises. In 2021, it achieved a 100% compliance rate for wastewater and waste gas emissions. Its subsidiary, Haibin Pharmaceutical, won the Shenzhen Sponge City Construction Project Award for its green and healthy project, "Haibin Pharmaceutical Factory Area." In 2021, HealthGen's MSCI ESG rating was upgraded to BBB.
For many years, HealthGen has always adhered to prioritizing social responsibility and wholeheartedly engaged in social welfare undertakings. Its public welfare actions cover areas such as universal chronic disease prevention and control, rural revitalization, support for education, disaster relief, and industry assistance, using practical actions to practice corporate social responsibility. HealthGen actively responds to the national policies on rural revitalization and common prosperity, combining its own industrial advantages to continuously carry out and implement the "Universal Chronic Disease Prevention and Control Public Welfare Project," covering 17 counties and districts in 8 provinces and 1 autonomous region, demonstrating the responsibility of pharmaceutical companies.
In the face of the global COVID-19 pandemic, HealthGen responded immediately to social needs, donating various epidemic prevention materials to protect frontline epidemic prevention workers. As a biopharmaceutical enterprise, HealthGen has always kept its mission in mind, responding to the call of the Party and the government, sparing no expense in researching and developing COVID-19 vaccines, antibodies, and antigen detection kits, and making contributions to epidemic prevention and control within its capacity. Since the recombinant COVID-19 fusion protein vaccine "Likang V-01" under HealthGen was approved for emergency use as a booster shot after being reviewed and approved by the National Medical Products Administration, booster shot vaccinations have been carried out in many provinces and cities across the country.
In the future, leaders in the commercial and capital markets will inevitably be enterprises with characteristics such as resource integration, social and environmental friendliness, and the "dual creation" of intrinsic and brand value. HealthGen will continue to explore the symbiotic relationship between corporate social responsibility and company development. While enjoying the resources and opportunities provided by society and the industry, it will repay society with steady and solid business development and caring public welfare actions, contributing to the construction of a healthy China and creating a green and beautiful future.
Source: Financial World Information
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.